A STUDY OF DUPILUMAB VERSUS PLACEBO IN PATIENTS WITH EOSINOPHILIC GASTRITIS WITH/WITHOUT EOSINOPHILIC DUODENITIS von Dellon, E., Rothenberg, M., Chehade, M., Maloney, J., Martincova, R., Paleczny, H., Glotfelty, L., Shabbir, A.

Volltext

DUPILUMAB IMPROVES OUTCOMES IN EOSINOPHILIC ESOPHAGITIS, REGARDLESS OF HISTORY OF FOOD ALLERGY OR DIETARY ELIMINATION von Spergel, J., Rothenberg, M., Cianferoni, A., Xia, C., Glotfelty, L., Shabbir, A.

Volltext

OC.08.5: DUPILUMAB IMPROVES INFLAMMATORY AND REMODELING ASPECTS OF ENDOSCOPIC DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE PHASE 3 LIBERTY-EOE-TREET STUDY von Pellegatta, G., Hirano, I., Collins, M.H., Dellon, E.S., Sun, X., Glotfelty, L., Shabbir, A.

Volltext

Considerations and best practices for 16S rRNA gene sequencing studies

Volltext

OC.08.3: DUPILUMAB EFFICACY IN EOSINOPHILIC ESOPHAGITIS PERSISTS FOR HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC OUTCOMES REGARDLESS OF CONCOMITANT HIGH-DOSE PROTON PUMP INHIBITOR USE von Pellegatta, G., Rothenberg, M.E., Dellon, E.S., Bredenoord, A.J., Sun, X., Laws, E., Mortensen, E., Maloney, J., Glotfelty, L., Shabbir, A.

Volltext

P726 A phase 2 study investigating the efficacy and safety of dupilumab versus placebo in adults with moderately to severely active ulcerative colitis with an eosinophilic phenotyp... von Gottlieb, E, Binion, D, Feagan, B, Laws, E, Nivens, C, Maloney, J, Abdulai, R, Radin, A, Glotfelty, L

Volltext

P665 Social Media Listening to better Understand the Lived Experience of Individuals With Ulcerative Colitis von Auriat, O, Lucats, L, Badalamenti, S, Kruger, A, Wiekowski, M, Glotfelty, L, Van Hoogstraten, H, Coulouvrat, C

Volltext

DUPILUMAB IMPROVES OUTCOMES IN EOSINOPHILIC ESOPHAGITIS, REGARDLESS OF HISTORY OF FOOD ALLERGY OR DIETARY ELIMINATION von Spergel, J., Rothenberg, M., Cianferoni, A., Xia, C., Glotfelty, L., Shabbir, A.

Volltext

A213 DUPILUMAB EFFICACY IN EOSINOPHILIC ESOPHAGITIS PERSISTS FOR HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC OUTCOMES REGARDLESS OF CONCOMITANT HIGH-DOSE PROTON PUMP INHIBITOR USE von Rothenberg, M, Dellon, E, Bredenoord, A J, Martire, E, Sun, X, Laws, E, Mortensen, E, Maloney, J, Glotfelty, L, Shabbir, A

Volltext

A204 DUPILUMAB IMPROVES HISTOLOGIC, ENDOSCOPIC, AND SYMPTOMATIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS IN PATIENTS AGES 1–ampersand:003C12 YEARS von Chehade, M, Dellon, E, Spergel, J M, Rothenberg, M E, Pesek, R D, Collins, M H, Hirano, I, Liu, R, Laws, E, Mortensen, E, Abdulai, R, Maloney, J, McCann, E, Kosloski, M P, Hamilton, J D, Samuely, C, Glotfelty, L, Shabbir, A, Chow, M

Volltext

Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease von Glotfelty, EJ, Olson, L, Karlsson, TE, Li, YZ, Greig, NH

Volltext

The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration von Li, Yazhou, Glotfelty, Elliot J., Karlsson, Tobias, Fortuno, Lowella V., Harvey, Brandon K., Greig, Nigel H.

Volltext

Corrigendum to “Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury” [Neurobiology of Disease Volume... von Bader, Miaad, Li, Yazhou, Lecca, Daniela, Rubovitch, Vardit, Tweedie, David, Glotfelty, Elliot, Rachmany, Lital, Kim, Hee Kyung, Choi, Ho-Il, Hoffer, Barry J., Pick, Chaim G., Greig, Nigel H., Kim, Dong Seok

Volltext

Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury von Li, Yazhou, Glotfelty, Elliot J., Namdar, Inbar, Tweedie, David, Olson, Lars, Hoffer, Barry J., DiMarchi, Richard D., Pick, Chagi G., Greig, Nigel H.

Volltext

The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia von Glotfelty, Elliot J, Tovar-Y-Romo, Luis B, Hsueh, Shih-Chang, Tweedie, David, Li, Yazhou, Harvey, Brandon K, Hoffer, Barry J, Karlsson, Tobias E, Olson, Lars, Greig, Nigel H

Volltext

The Chandra Source Catalog von Evans, Ian N, Primini, Francis A, Glotfelty, Kenny J, Anderson, Craig S, Bonaventura, Nina R, Chen, Judy C, Davis, John E, Doe, Stephen M, Evans, Janet D, Fabbiano, Giuseppina, Galle, Elizabeth C, Gibbs, Danny G, Grier, John D, Hain, Roger M, Hall, Diane M, Harbo, Peter N, He, Xiangqun (Helen), Houck, John C, Karovska, Margarita, Kashyap, Vinay L, Lauer, Jennifer, McCollough, Michael L, McDowell, Jonathan C, Miller, Joseph B, Mitschang, Arik W, Morgan, Douglas L, Mossman, Amy E, Nichols, Joy S, Nowak, Michael A, Plummer, David A, Refsdal, Brian L, Rots, Arnold H, Siemiginowska, Aneta, Sundheim, Beth A, Tibbetts, Michael S, Van Stone, David W, Winkelman, Sherry L, Zografou, Panagoula

Volltext

Microglial Nogo delays recovery following traumatic brain injury in mice von Glotfelty, Elliot J., Hsueh, Shih‐Chang, Claybourne, Quia, Bedolla, Alicia, Kopp, Katherine O., Wallace, Tonya, Zheng, Binhai, Luo, Yu, Karlsson, Tobias E., McDevitt, Ross A., Olson, Lars, Greig, Nigel H.

Volltext

Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury von Bader, Miaad, Li, Yazhou, Lecca, Daniela, Rubovitch, Vardit, Tweedie, David, Glotfelty, Elliot, Rachmany, Lital, Kim, Hee Kyung, Choi, Ho-Il, Hoffer, Barry J., Pick, Chaim G., Greig, Nigel H., Kim, Dong Seok

Volltext

When population growth intensifies intergroup competition, female colobus monkeys free-ride less von Arseneau-Robar, T. Jean, Teichroeb, Julie A., Macintosh, Andrew J. J., Saj, Tania L., Glotfelty, Emily, Lucci, Sara, Sicotte, Pascale, Wikberg, Eva C.

Volltext

Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury von Glotfelty, Elliot J, Delgado, Thomas E, Tovar-y-Romo, Luis B, Luo, Yu, Hoffer, Barry J, Olson, Lars, Karlsson, Tobias E, Mattson, Mark P, Harvey, Brandon K, Tweedie, David, Li, Yazhou, Greig, Nigel H

Volltext